// App-Quantinova.ai

BSH2020‐EP‐017 : CAR‐T therapy as a curative option for childhood acute lymphoblastic leukaemia (ALL) in developing countries?

Researchers

Presenter

  • Z. Lim

Principal Investigators

  • E. Setiawan

  • M. Aisyi

  • L. Setiawan

  • R. Dina Garniasih

  • W. Rathnayake

  • P. Bora

  • T. O. Lim

Medical Centers

  • University College Hospital, London,

  • Dharmais National Cancer Centre

  • HARKIT Hospital, Jakarta, Indonesia

  • National Cancer Institute Maharagama , Colombo, Sri Lanka

  • National Cancer Centre Calmette Hospital, Phnom Penh, Cambodia

  • ClinResearch SB, Selangor, Malaysia

Locations

  • United Kingdom

  • Indonesia

  • Sri Lanka

  • Cambodia

  • Malaysia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Cytokine release syndrome

  • Leptomeningeal Metastasis

  • Mismatch repair deficiency

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Coxsackie Virus And Adenovirus Receptor

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Tocilizumab

  • Allopurinol

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A